Biotech10 months ago
AstraZeneca Seeks to Improve its Vaccine Plant in Liverpool with £100 Million
In December 2023, the company reached an agreement to acquire the entire share capital of the Chinese start-up Gracell Biotechnologies for a price that could reach...